A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave

Evans M, McDonald AC, Xiong L, et al. (2021) Neurology and therapy
Title and abstract of A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave

Key Takeaway

A single 200mg dose of L-theanine significantly increased alpha brain wave power within 1 hour and reduced heart rate and blood pressure during a cognitive stress task compared to placebo in a crossover RCT of 30 healthy adults.

Summary

This triple-blind, placebo-controlled, crossover RCT investigated the acute effects of a single 200mg dose of L-theanine (AlphaWave brand) on stress-related physiological markers in 30 healthy adults. The crossover design meant each participant served as their own control, receiving both L-theanine and placebo in random order with a washout period between sessions. Stress was induced using a validated multitasking cognitive stressor framework.

The study measured both neurological (EEG alpha brain waves) and cardiovascular (heart rate, blood pressure) responses. L-theanine significantly increased frontal alpha brain wave power compared to placebo within 60 minutes of ingestion. During the cognitive stress task, participants who received L-theanine showed lower heart rate and reduced systolic and diastolic blood pressure compared to the placebo condition, suggesting an attenuation of the physiological stress response.

These findings are particularly relevant because they demonstrate that L-theanine produces measurable physiological changes from a single dose, confirming the rapid onset of action. The increase in alpha brain waves aligns with the subjective experience of "calm alertness" commonly reported by users. The cardiovascular findings provide an objective mechanism for L-theanine's anxiolytic properties, showing it dampens the sympathetic nervous system response to stress.

Methods

Triple-blind, placebo-controlled, crossover RCT with 30 healthy adults (18-50 years). Participants received a single 200mg dose of L-theanine (AlphaWave) or placebo in randomized order with a washout period. EEG was recorded to measure alpha brain wave power. Heart rate and blood pressure were measured before and during a validated cognitive multitasking stress test. Each participant completed both conditions.

Key Results

  • Frontal alpha power: Significantly increased with L-theanine vs placebo (p < 0.05) within 60 minutes
  • Whole-scalp alpha power: Also significantly increased with L-theanine
  • Heart rate: Significantly reduced during stress task with L-theanine vs placebo
  • Systolic blood pressure: Significantly lower with L-theanine during stress
  • Diastolic blood pressure: Significantly lower with L-theanine during stress
  • Effects observed from a single 200mg dose
  • No adverse events reported

Figures

Limitations

  • Small sample size (n=30), though crossover design improves statistical power
  • Single-dose study does not address chronic supplementation effects
  • Healthy adult population only; results may differ in clinical populations
  • Used a branded supplement (AlphaWave); results may not generalize to all L-theanine products
  • Acute stress was laboratory-induced; real-world stress response may differ
  • Short follow-up period (single session per condition)

Related Interventions

Related Studies

More by Evans

Source

View on PubMed →

DOI: 10.1007/s40120-021-00284-x